Malignant melanoma - Interferon alpha: an important option in the therapy of high-risk patients

被引：0
|
作者：
不详
机构：
来源：
HAUTARZT | 2005年 / 56卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：1190 / 1190
页数：1
相关论文
共 50 条
  • [1] ADJUVANT THERAPY OF HIGH-RISK MALIGNANT-MELANOMA PATIENTS WITH GAMMA-INTERFERON
    LANDTHALER, M
    BRAUNFALCO, O
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1989, 20 (04) : 687 - 688
  • [2] Adjuvant therapy for patients with high-risk malignant melanoma
    McClay, EF
    SEMINARS IN ONCOLOGY, 2002, 29 (04) : 389 - 399
  • [3] Interferon Alpha Adjuvant Therapy in Patients With High-Risk Melanoma: A Systematic Review and Meta-analysis
    Mocellin, Simone
    Pasquali, Sandro
    Rossi, Carlo R.
    Nitti, Donato
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (07): : 493 - 501
  • [4] LONG-TERM ADJUVANT THERAPY OF HIGH-RISK MALIGNANT-MELANOMA WITH INTERFERON-ALPHA-2B
    KOKOSCHKA, EM
    TRAUTINGER, F
    KNOBLER, RM
    POHLMARKL, H
    MICKSCHE, M
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1990, 95 (06) : S193 - S197
  • [5] The role of BRAF mutation in patients with high-risk malignant melanoma treated with high-dose adjuvant interferon therapy
    Akman, Tulay
    Oztop, Ilhan
    Baskin, Yasemin
    Akbarpour, Mahdi
    Unal, Olcun Umit
    Oflazoglu, Utku
    Ellidokuz, Hulya
    MEDICAL ONCOLOGY, 2015, 32 (01) : 1 - 10
  • [6] The role of BRAF mutation in patients with high-risk malignant melanoma treated with high-dose adjuvant interferon therapy
    Tulay Akman
    Ilhan Oztop
    Yasemin Baskin
    Mahdi Akbarpour
    Olcun Umit Unal
    Utku Oflazoglu
    Hulya Ellidokuz
    Medical Oncology, 2015, 32
  • [7] Update on adjuvant interferon therapy for high-risk melanoma
    Agarwala, SS
    Kirkwood, JM
    ONCOLOGY-NEW YORK, 2002, 16 (09): : 1177 - 1187
  • [8] Elective radiation therapy for high-risk malignant melanoma
    Cooper, JS
    Chang, WS
    Oratz, R
    Shapiro, RL
    Roses, DF
    CANCER JOURNAL, 2001, 7 (06): : 522 - 522
  • [9] Erratum to: The role of BRAF mutation in patients with high-risk malignant melanoma treated with high-dose adjuvant interferon therapy
    Tulay Akman
    Ilhan Oztop
    Yasemin Baskin
    Mahdi Akbarpour
    Olcun Umit Unal
    Utku Oflazoglu
    Hulya Ellidokuz
    Banu Lebe
    Medical Oncology, 2015, 32
  • [10] Adjuvant high-dose interferon therapy for high-risk melanoma
    Ready, N
    Weinstock, MA
    ARCHIVES OF DERMATOLOGY, 2003, 139 (12) : 1635 - 1637
12345